Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Mondelez, CVS Health, Shell And A Major Retailer On CNBC's 'Final Trades'

Published 18/10/2023, 13:20
© Reuters.  Mondelez, CVS Health, Shell And A Major Retailer On CNBC's 'Final Trades'
COST
-
CVS
-
SHEL
-
MDLZ
-

Benzinga - by Lisa Levin, Benzinga Editor.

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors said Mondelez International, Inc. (NASDAQ: MDLZ), has "fantastic" organic growth.

On Tuesday, Exane BNP Paribas analyst Max Gumport upgraded Mondelez International from Neutral to Outperform, while BofA Securities analyst Bryan Spillane maintained the stock with a Buy and lowered the price target from $82 to $78.

Jim Lebenthal of Cerity Partners named CVS Health Corporation (NYSE: CVS) as his final trade.

Walgreens Boots Alliance and CVS Health CVS pharmacy staff are reportedly planning a nationwide walkout and multiple rallies in late October to protest poor working conditions.

Don’t forget to check out our premarket coverage here

Amy Raskin of Chevy Chase Trust said Shell plc (NYSE: SHEL) stock is still cheap with a nice dividend.

Shell expanded collaboration with C3.ai, an AI application software company, for predictive maintenance (control valves and critical equipment).

Joseph Terranova of Virtus Investment Partners said Costco Wholesale Corporation (NASDAQ: COST) is trading near its high for the year.

Costco Wholesale is facing legal action, accused of sharing sensitive customer information with Meta Platforms, the parent company of Facebook, without the customers' approval.

Price Action: Costco gained 0.4% to close at $574.34, while Shell rose 0.5% to settle at $68.48 on Tuesday. CVS Health shares gained 0.7% to close at $72.01, while Mondelez added 1.5% to $63.54 during Tuesday’s session.

Check This Out: Accenture, Robinhood And 2 Other Stocks Insiders Are Selling

Photo: Shutterstock

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.